Hematological alterations in cancer patients can be very particular and it is important to know them in order to implement timely therapeutic corrections. They tend to be different at each stage of the disease and could be used as biomarkers of the response to chemotherapy treatment. Some of these alterations are of diagnostic relevance and can lead to in oncology emergencies.
Resúmen
Las alteraciones hematológicas en los pacientes con cáncer pueden llegar a ser muy particulares y es importante conocerlas para implementar correcciones terapéuticas oportunas. Suelen ser diferentes en cada etapa de la enfermedad y podrían utilizarse como biomarcadores de la respuesta al tratamiento quimioterapéutico. Algunas de dichas alteraciones son de relevancia diagnóstica y pueden derivar en urgencias oncológicas.
Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sept | Oct | Nov | Dic |
---|---|---|---|---|---|---|---|---|---|---|---|
- | 10 | 21 | 20 | 14 | 7 | 9 | 18 | 7 | 11 | 24 | 4 |
Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sept | Oct | Nov | Dic |
---|---|---|---|---|---|---|---|---|---|---|---|
11 | 4 | 13 | 5 | 11 | 4 | 8 | 12 | 19 | 10 | 22 | 4 |
Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sept | Oct | Nov | Dic |
---|---|---|---|---|---|---|---|---|---|---|---|
16 | 14 | 12 | 11 | 7 | - | - | - | - | - | - | - |
(2005). Hyperviscosity syndrome in hematological
diseases and therapeutic apheresis. The
International journal of artifi cial organs, 28(10),
1032-1038.
Beurlet, S., Krief, P., Sansonetti, A., Briend-Marchal,
A., Kiladjian, J. J., Padua, R. A., ... & Cassinat, B.
(2011). Identifi cation of JAK2 mutations in canine
primary polycythemia. Experimental hematology,
39(5), 542-545.
Blackwood, L., Murphy, S., Buracco, P., De Vos, J. P.,
De Fornel‐Thibaud, P., Hirschberger, J., Kessler, M.,
Pastor, J., Ponce, F., Savary-Bataille, K. & Argyle,
D. J. (2012). European consensus document on
mast cell tumours in dogs and cats. Veterinary and
comparative oncology, 10(3), e1-e29.
Bromberek, J. L., Rout, E. D., Agnew, M. R.,
Yoshimoto, J., Morley, P. S. & Avery, A. C. (2016).
Breed distribution and clinical characteristics of B
cell chronic lymphocytic leukemia in dogs. Journal
of veterinary internal medicine, 30(1), 215-222.
Bruchim, Y., Aroch, I., Saragusty, J. & Waner, T.
(2008). Disseminated intravascular coagulation.
Compendium, 3(10), 1-16.
Childress, M. O. (2012). Hematologic abnormalities
in the small animal cancer patient. Veterinary Clinics:
Small Animal Practice, 42(1), 123-155.
Clermont, T., Leblanc, A. K., Adams, W. H., Leblanc,
C. J. & Bartges, J. W. (2012). Radiotherapy‐induced
myelosuppression in dogs: 103 cases (2002-2006).
Veterinary and comparative oncology, 10(1), 24-32.
Coee, C., Roush, J. K. & Higginbotham, M. L. (2020).
Carboplatin‐induced myelosuppression as related to
body weight in dogs. Veterinary and comparative
oncology, 18(4), 804-810.
Comazzi, S., Gelain, M. E., Bonfanti, U. & Roccabianca,
P. (2010). Acute megakaryoblastic leukemia in dogs:
a report of three cases and review of the literature.
Journal of the American Animal Hospital Association,
46(5), 327-335.
Dos Santos Cunha, S. C., Silva, F. B. F., Corgozinho,
K. B., Da Silva, K. G. C. & Ferreira, A. M. R. (2017).
Adverse Eects of Chemotherapy in Dogs. World,
7(3), 74-82.
Finlay, J., Wyatt, K. & Black, M. (2017). Evaluation
of the risks of chemotherapy in dogs with
thrombocytopenia. Veterinary and comparative
oncology, 15(1), 151-162.
Garden, O. A., Kidd, L., Mexas, A. M., Chang, Y. M.,
Jeery, U., Blois, S. L., ... & Szladovits, B. (2019).
ACVIM consensus statement on the diagnosis of
immune‐mediated hemolytic anemia in dogs and
cats. Journal of veterinary internal medicine, 33(2),
313-334. doi: 10.1111/jvim.15441
Hall, A. M., Vickers, M. A., McLeod, E. & Barker, R. N.
(2005). Rh autoantigen presentation to helper T
cells in chronic lymphocytic leukemia by malignant
B cells. Blood, 105(5), 2007-2015.
Harper, A. & Blackwood, L. (2017). Toxicity and
response in cats with neoplasia treated with
toceranib phosphate. Journal of feline medicine and
surgery, 19(6), 619-623.
Hergt, F., Mortier, F., Werres, C., Flatz, K. & von Bomhard,
W. (2019). Renal nephroblastoma in a 17-month-old
jack Russell terrier. Journal of the American Animal
Hospital Association, 55(5), e55503.
Michael, A. E., Grimes, J. A., Volstad, N. J., Osekavage,
K. E. & Koenig, A. (2019). Inappropriate secondary
erythrocytosis in a dog with renal sarcoma. Topics in
companion animal medicine, 36, 9-11.
Miller, A. G., Morley, P. S., Rao, S., Avery, A. C., Lana,
S. E. & Olver, C. S. (2009). Anemia is associated with
decreased survival time in dogs with lymphoma.
Journal of veterinary internal medicine, 23(1), 116-
122.
Mizukoshi, T., Fujino, Y., Yasukawa, K., Matumoto, H.,
Matsumura, S., Nagasaki, T., ... & Shimoda, T. (2006).
Essential thrombocythemia in a dog. Journal of
veterinary medical science, 68(11), 1203-1206.
Mullin, C. & Cliord, C. A. (2019). Histiocytic sarcoma
and hemangiosarcoma update. Veterinary Clinics:
Small Animal Practice, 49(5), 855-879.
Petterino, C., Luzio, E., Baracchini, L., Ferrari, A. &
Ratto, A. (2011). Paraneoplastic leukocytosis in a dog
with a renal carcinoma. Veterinary clinical pathology,
40(1), 89-94.
Sato, K., Hikasa, Y., Morita, T., Shimada, A., Ozaki,
K. & Kagota, K. (2002). Secondary erythrocytosis
associated with high plasma erythropoietin
concentrations in a dog with cecal leiomyosarcoma.
Journal of the American Veterinary Medical
Association, 220(4), 486-490.
Schultze, A. E. (2010). Interpretation of canine leukocyte
responses. Schalm’s veterinary hematology
(pp. 321-334). Ames, Iowa: Wiley-Blackwell.
Sherwood, J. M., Haynes, A. M., Klocke, E., Higginbotham,
M. L., Thomson, E. M., Weng, H. Y. & Towle
Millard, H. A. (2016). Occurrence and clinicopathologic
features of splenic neoplasia based on body
weight: 325 Dogs (2003–2013). Journal of the
American Animal Hospital Association, 52(4), 220-
226.
Stokol, T. (2012). Laboratory diagnosis of disseminated
intravascular coagulation in dogs and cats:
the past, the present, and the future. Veterinary
Clinics: Small Animal Practice, 42(1), 189-202.
Tarrant, J. M., Stokol, T., Blue, J. T., McDonough, S. P.
& Farrell, P. (2001). Diagnosis of chronic myelogenous
leukemia in a dog using morphologic, cytochemical,
and flow cytometric techniques. Veterinary
clinical pathology, 30(1), 19-24.
Tasca, S., Carli, E., Caldin, M., Menegazzo, L., Furlanello,
T. & Gallego, L. S. (2009). Hematologic abnormalities
and flow cytometric immunophenotyping
results in dogs with hematopoietic neoplasia: 210
cases (2002–2006). Veterinary clinical pathology,
38(1), 2-12.
Taylor, A., Finotello, R., Vilar‐Saavedra, P., Couto, C.
G., Benigni, L. & Lara‐Garcia, A. (2019). Clinical characteristics
and outcome of dogs with presumed
primary renal lymphoma. Journal of Small Animal
Practice, 60(11), 663-670.
Tomiyasu, H., Doi, A., Chambers, J. K., Goto‐Koshino,
Y., Ohmi, A., Ohno, K. & Tsujimoto, H. (2018).
Clinical and clinicopathological characteristics of
acute lymphoblastic leukaemia in six cats. Journal
of Small Animal Practice, 59(12), 742-746.
Tumielewicz, K. L., Hudak, D., Kim, J., Hunley, D. W. &
Murphy, L. A. (2019). Review of oncological emergencies
in small animal patients. Veterinary medicine
and science, 5(3), 271-296.
Weiss, D. J. & Wardrop, K. J. (eds.). (2010). Schalm’s
veterinary hematology. John Wiley & Sons.
Weltan, S. M., Leisewitz, A. L. & Goddard, A. (2008).
A case‐controlled retrospective study of the causes
and implications of moderate to severe leukocytosis
in dogs in South Africa. Veterinary clinical
pathology, 37(2), 164-172.
Woolcock, A. D., Keenan, A., Cheung, C., Christian,
J. A. & Moore, G. E. (2017). Thrombocytosis in 715
Dogs (2011-2015). Journal of veterinary internal
medicine, 31(6), 1691-1699.
Yamauchi, A., Ohta, T., Okada, T., Mochizuki, M., Nishimura,
R., Matsunaga, S., ... & Sasaki, N. (2004).
Secondary erythrocytosis associated with schwannoma
in a dog. Journal of veterinary medical science,
66(12), 1605-1608.
Zandvliet, M. (2016). Canine lymphoma: a review.
Veterinary Quarterly, 36(2), 76-104.